Novartis, MSN Pharma agree to dismiss Kisqali patent lawsuit
Novartis (NYSE:NVS) and MSN Pharmaceuticals have reached agreement in a Delaware federal court to dismiss patent litigation related to MSN's attempt to launch a generic of the former's Kisqali ...
AbbVie Vs. Novartis: Which Has The Technical Edge Before Q4 Earnings?
AbbVie and Novartis to report Q4 earnings. AbbVie in stagnating trend, Novartis bullish. Breakdown of technical charts. Novartis has advantage, investors watch for post-earnings movement.
U.S. FDA nod for Natco Pharma’s generic of Novartis drug
Natco Pharma receives FDA approval for Everolimus tablets, launching generic version of Afinitor Disperz in U.S. market.
money.rediff12h
Natco Pharma Gets US FDA Approval for Generic Everolimus Tablets
Natco Pharma has received US FDA approval for its generic version of Everolimus tablets for oral suspension, indicated for ...
Natco Pharma receives approval for its ANDA for Everolimus tablets for oral suspension
Natco Pharma announced approval of its ANDA for Everolimus tablets for oral suspension (TFOS), 2mg, 3mg and 5mg, a generic version of AFINITOR DISPERZ by Novartis Pharmaceutical Corporation. NATCO's ...
Novartis's SWOT analysis: pharma giant's stock faces pipeline and pricing pressures
Novartis AG (NYSE:NVS), a global healthcare company valued at over $206 billion, has undergone significant transformation in recent years, focusing its efforts on becoming a pure-play pharmaceutical ...
Hailee Steinfeld Reveals Why Super Bowl 2025 Is Her 'Bucket List' Dream—And It Has Nothing to Do With Josh Allen
Hailee Steinfeld will feature in a Novartis Super Bowl 2025 commercial on breast cancer awareness, a significant engagement ...